Phase 4 N=60 Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety
Anxiety Disorder
Primary: Magnitude of Startle Reflex During Safe Condition — 42.2880893; 42.39801; 43.61243; 44.1886408 millivolts (mV)
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=1,063 Brain Imaging Changes in Fear and Anxiety
Anxiety Disorders · Fear
Primary: Average Correlations Between Average Time Series - Left & Right Hemisphere of the Brain — 0.9; 0.92 correlation coefficient (r) — p=< 0.001
N/A N=50 A Cognitive Behavioral Therapy (CBT) Intervention to Reduce Fear of Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus
Primary: Fear of Hypoglycemia — 54.3; 58.7; 35.29; 49.0 units on a scale
N/A N=89 Targeting Reconsolidation to Prevent Return of Fear
Fear of Flying
Primary: Fear of Flying Inventory (FFI) — 65.55; 76.57 units on a scale
N/A N=67 The Effect of Intravenous Anesthetics on Fear Learning and Memory
Phobias
Primary: GSR Trial 1 — .62; .55; .55; .67 units on a scale
N/A N=918 Expectation of Unpleasant Events in Anxiety Disorders
Anxiety Disorders
Primary: Change in Percent of Correct Button Presses During Threat Compared to the Safe Condition (AAST) — -0.016; 0.008 Percentage of accurate responses
N/A N=59 A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment
Anxiety Disorders
Primary: Screen for Child Anxiety Related Emotional Disorders - Parent Version at Posttreatment — 35; 30 units on a scale
Phase 4 N=172 Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders
Posttraumatic Stress Disorder · Anxiety Disorder
Primary: Change From Baseline Skin Conductance Response — .06; .17; -1.27; -.04 microSiemens — p=>.05
Phase 4 N=46 Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study
PostTraumatic Stress Disorder
Primary: Brain Measures — 0.039567327; 0.092173636; 0.149446357; -0.021618 arbitrary units — p=< 0.05
N/A N=86 Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder
Post-Traumatic Stress Disorder
Primary: Brain Measures — -0.08; 0.27; 0.02; 0.03 arbitrary units — p=>0.05
N/A N=23 Treating Phobia With Multivoxel Neuro-reinforcement
Phobia
Primary: Change in Amygdala Reactivity — -.691; -.827; -.278 Beta Coefficient
Phase 1 N=40 Feasibility of Aromatherapy in an Awake Craniotomy Environment
Intracranial Pathology
Primary: Number of Consented Patients — 40 Participants
N/A N=193 Pain Monitoring After Breast Biopsy: Benefit of E-health
Breast Cancer · Biopsy Wound
Primary: Number of Participants by Pain Intensity at Day 4 Post Breast Biopsy With a Benefit of Intervention by E-health (Phone Consultation With a Professional or Connected…
Phase 2 N=70 Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
Alcohol-Related Disorders · Alcohol Dependence · Alcoholism
Primary: Alcohol Craving in Response to the Alcohol Cue Script — 12.7; 10.7 Units on a scale
N/A N=93 The Effect of Vibration and Cold on Pain and Anxiety Associated With Chest Tube Removal Following CABG
Pain, Procedural · Pain, Postoperative · Coronary Artery Bypass Surgery
Primary: Mediastinal Chest Tube Pain — 1.38; 1.76; 1.43; 0.21 score on a scale